Cancer survivorship at heart : a multidisciplinary cardio-oncology roadmap for healthcare professionals
© 2023 Bisceglia, Canale, Silvestris, Gallucci, Camerini, Inno, Camilli, Turazza, Russo, Paccone, Mistrulli, De Luca, Di Fusco, Tarantini, Lucà, Oliva, Moreo, Maurea, Quagliariello, Ricciardi, Lestuzzi, Fiscella, Parrini, Racanelli, Russo, Incorvaia, Calabrò, Curigliano, Cinieri, Gulizia, Gabrielli, Oliva and Colivicchi..
In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of life. With improvements in early diagnosis and treatment, the number of cancer survivors (CS) has grown considerably and includes: (1) Patients cured and free from cancer who may be at risk of late-onset cancer therapy-related cardiovascular toxicity (CTR-CVT); (2) Patients with long-term control of not-curable cancers in whom CTR-CVT may need to be addressed. This paper highlights the importance of the cancer care continuum, of a patient-centered approach and of a prevention-oriented policy. The ultimate goal is a personalized care of CS, achievable only through a multidisciplinary-guided survivorship care plan, one that replaces the fragmented management of current healthcare systems. Collaboration between oncologists and cardiologists is the pillar of a framework in which primary care providers and other specialists must be engaged and in which familial, social and environmental factors are also taken into account.
| Errataetall: |
ErratumIn: Front Cardiovasc Med. 2023 Oct 25;10:1309921. - PMID 37953759 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Frontiers in cardiovascular medicine - 10(2023) vom: 13., Seite 1223660 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 13.11.2023 published: Electronic-eCollection ErratumIn: Front Cardiovasc Med. 2023 Oct 25;10:1309921. - PMID 37953759 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fcvm.2023.1223660 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362803196 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362803196 | ||
| 003 | DE-627 | ||
| 005 | 20231226092013.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fcvm.2023.1223660 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1209.xml |
| 035 | |a (DE-627)NLM362803196 | ||
| 035 | |a (NLM)37786510 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bisceglia, Irma |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cancer survivorship at heart |b a multidisciplinary cardio-oncology roadmap for healthcare professionals |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.11.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumIn: Front Cardiovasc Med. 2023 Oct 25;10:1309921. - PMID 37953759 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 Bisceglia, Canale, Silvestris, Gallucci, Camerini, Inno, Camilli, Turazza, Russo, Paccone, Mistrulli, De Luca, Di Fusco, Tarantini, Lucà, Oliva, Moreo, Maurea, Quagliariello, Ricciardi, Lestuzzi, Fiscella, Parrini, Racanelli, Russo, Incorvaia, Calabrò, Curigliano, Cinieri, Gulizia, Gabrielli, Oliva and Colivicchi. | ||
| 520 | |a In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of life. With improvements in early diagnosis and treatment, the number of cancer survivors (CS) has grown considerably and includes: (1) Patients cured and free from cancer who may be at risk of late-onset cancer therapy-related cardiovascular toxicity (CTR-CVT); (2) Patients with long-term control of not-curable cancers in whom CTR-CVT may need to be addressed. This paper highlights the importance of the cancer care continuum, of a patient-centered approach and of a prevention-oriented policy. The ultimate goal is a personalized care of CS, achievable only through a multidisciplinary-guided survivorship care plan, one that replaces the fragmented management of current healthcare systems. Collaboration between oncologists and cardiologists is the pillar of a framework in which primary care providers and other specialists must be engaged and in which familial, social and environmental factors are also taken into account | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a cancer survivors (CSs) | |
| 650 | 4 | |a cancer therapy-related cardiovascular toxicities (CTR-CVT) | |
| 650 | 4 | |a cardiovascular disease (CVD) | |
| 650 | 4 | |a cardiovascular risk factors (CVRF) | |
| 650 | 4 | |a reverse cardio-oncology | |
| 650 | 4 | |a survivorship care | |
| 700 | 1 | |a Canale, Maria Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Silvestris, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Gallucci, Giuseppina |e verfasserin |4 aut | |
| 700 | 1 | |a Camerini, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Inno, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Camilli, Massimiliano |e verfasserin |4 aut | |
| 700 | 1 | |a Turazza, Fabio Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Russo, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Paccone, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Mistrulli, Raffaella |e verfasserin |4 aut | |
| 700 | 1 | |a De Luca, Leonardo |e verfasserin |4 aut | |
| 700 | 1 | |a Di Fusco, Stefania Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Tarantini, Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Lucà, Fabiana |e verfasserin |4 aut | |
| 700 | 1 | |a Oliva, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Moreo, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Maurea, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Quagliariello, Vincenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Ricciardi, Giuseppina Rosaria |e verfasserin |4 aut | |
| 700 | 1 | |a Lestuzzi, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Fiscella, Damiana |e verfasserin |4 aut | |
| 700 | 1 | |a Parrini, Iris |e verfasserin |4 aut | |
| 700 | 1 | |a Racanelli, Vito |e verfasserin |4 aut | |
| 700 | 1 | |a Russo, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Incorvaia, Lorena |e verfasserin |4 aut | |
| 700 | 1 | |a Calabrò, Fabio |e verfasserin |4 aut | |
| 700 | 1 | |a Curigliano, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Cinieri, Saverio |e verfasserin |4 aut | |
| 700 | 1 | |a Gulizia, Michele Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Gabrielli, Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Oliva, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Colivicchi, Furio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in cardiovascular medicine |d 2014 |g 10(2023) vom: 13., Seite 1223660 |w (DE-627)NLM255534736 |x 2297-055X |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g day:13 |g pages:1223660 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fcvm.2023.1223660 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2023 |b 13 |h 1223660 | ||